# Mediating factors in the relationship between combat-related traumatic injury and myocardial blood flow reserve: The ADVANCE cohort study

**Authors:** Christopher J Boos, Susie Schofield, Rabeea Maqsood, Anthony MJ Bull, Nicola T Fear, Paul Cullinan, Harriet Kemp, Alexander N Bennett, Niema Pahlevan, Niema Pahlevan, Niema Pahlevan

PMC · DOI: 10.1371/journal.pone.0345019 · PLOS One · 2026-03-19

## TL;DR

Combat injuries are linked to reduced heart blood flow, with body fat and physical activity playing key roles in this connection.

## Contribution

Identifies visceral fat mass, heart rate variability, and physical activity as mediators between combat injury and reduced myocardial blood flow reserve.

## Key findings

- Visceral fat mass and heart rate variability significantly mediate the relationship between combat injury and reduced SEVR.
- Physical activity levels also mediate this relationship, suggesting potential intervention targets.
- Amputees showed the lowest SEVR, with mediation effects from visceral fat and heart rate variability.

## Abstract

Combat-related traumatic injury (CRTI) has been linked to reduced myocardial blood-flow- reserve (MBFR), measured using the subendocardial viability ratio (SEVR). We aimed to assess the mediating role of known cardiovascular risk factors on SEVR.

We examined 1018 UK servicemen (prospective ADVANCE Cohort Study) comprising 504 with CRTI (140 amputees) and 514 uninjured men, frequency-matched at sampling, by age, rank and deployment (Afghanistan 2003–2014). We examined the mediating role of cardiovascular risk factors, shown to significantly greater with CRTI at study baseline (~8 years post-injury/deployment), on SEVR, measured three-years later (FU1). The cardiovascular risk measures were heart-rate variability (HRV, root-mean-square-of-successive-differences [RMSSD]), visceral-fat-mass (VFM, using DEXA), venous-blood high-sensitivity C-reactive protein (Hs-CRP, inflammation), six-minute walk distance (6MWD, physical function) and weekly leisure-time moderate-to-vigorous physical activity (LT-MVPA, physical activity).

At baseline, VFM was significantly greater and RMSSD, 6MWD and LT-MVPA lower with CRTI compared to the uninjured. VFM and Hs-CRP were significantly greater and RMSSD, 6MWD and LT-MVPA lower in the injured amputees versus the injured non-amputees and uninjured. The SEVR at FU1 was significantly lower in the injured (mean ± standard deviation; 187.2 ± 39.7) compared to the uninjured (194.1 ± 31.5) and lowest in the amputee sub-group (181.9 ± 30.0). The association between CRTI and SEVR was mediated by VFM (natural indirect effect −1.80: 95%CI: −2.90, −0.67), RMSSD (−1.82: −3.45, −0.19) and 6MWD (−1.79: −3.16, −0.41) but not Hs-CRP and LT-MVPA. The association between traumatic amputation and SEVR was mediated by VFM, HRV and LT-MVPA.

VFM, HRV and physical function/activity were significant mediators of the link between CRTI and SEVR. Interventions on physical activity/function could mitigate the association between CRTI and SEVR. Data from longer-term follow up are required to robustly determine the temporal effects of this relationship.

## Full-text entities

- **Genes:** LGALS3 (galectin 3) [NCBI Gene 3958] {aka CBP35, GAL3, GALBP, GALIG, L31, LGALS2}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** Injury (MESH:D014947), amputation (MESH:C565682), infection (MESH:D007239), blast injuries (MESH:D001753), ADVANCE (MESH:D001134), Cardiovasc Disord (MESH:D009358), stroke (MESH:D020521), combat injury (MESH:D003130), limb loss (MESH:D001259), VFM (MESH:C536030), traumatic amputation (MESH:D000673), coronary heart disease (MESH:D003327), Obesity (MESH:D009765), depression (MESH:D003866), sarcopenia (MESH:D055948), long-term cardiovascular consequences (MESH:D000088562), insomnia (MESH:D007319), PTSD (MESH:D013313), abdominal obesity (MESH:D056128), metabolic syndrome (MESH:D024821), Cardiovascular disease (MESH:D002318), pain (MESH:D010146), hypertension (MESH:D006973), endothelial dysfunction (MESH:D014652), adiposity (MESH:D018205), arrhythmias (MESH:D001145), Vascular inflammation (MESH:D007249), coronary artery disease (MESH:D003324), rheumatoid arthritis (MESH:D001172), anxiety (MESH:D001007), TBI (MESH:D000070642), RMSSD (MESH:D011843), diabetes (MESH:D003920), amputees (MESH:D000081042), atherosclerosis (MESH:D050197), subendocardial ischemia (MESH:D007511)
- **Chemicals:** PONE-D-25-50727R1 (-), Cholesterol (MESH:D002784), nitrates (MESH:D009566), caffeine (MESH:D002110), cortisol (MESH:D006854), oxygen (MESH:D010100), Viagra (MESH:D000068677), metal (MESH:D008670), alcohol (MESH:D000438), glucose (MESH:D005947), lipid (MESH:D008055), triglyceride (MESH:D014280)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A1C

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13001918/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13001918/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC13001918/full.md

---
Source: https://tomesphere.com/paper/PMC13001918